Kazia Therapeutics
KZIA
9 hedge funds and large institutions have $897K invested in Kazia Therapeutics in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
428% more capital invested
Capital invested by funds: $170K → $897K (+$727K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
13% more funds holding
Funds holding: 8 → 9 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$296K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$115K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$61.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$25.2K |
| 5 |
Citigroup
New York
|
+$3.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$93.5K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$31K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$2.87K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
KZIA Hedge Fund Activity: Q1 2015 in Review
9 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q1 2015, worth a combined $897K — up 428% from $170K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new KZIA positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $296K. The largest seller was Jane Street, cutting an estimated $93.5K.
- 9 institutional investors held Kazia Therapeutics (KZIA) as of Q1 2015, up from 8 in Q4 2014.
- Funds reported $897K of Kazia Therapeutics stock for Q1 2015, up 428% quarter-over-quarter.
- 3 funds opened new Kazia Therapeutics positions in Q1 2015 and 2 closed out, a net change of +1 holder.
- The largest Kazia Therapeutics buyer in Q1 2015 was Renaissance Technologies, an estimated $296K added.
- The largest Kazia Therapeutics seller in Q1 2015 was Jane Street, an estimated $93.5K sold.
Based on aggregated 13F filings for Q1 2015.